tiprankstipranks
Pharmaron Beijing Co., Ltd. Class H (HK:3759)
:3759
Hong Kong Market

Pharmaron Beijing Co., Ltd. Class H (3759) Income Statement

Compare
5 Followers

Pharmaron Beijing Co., Ltd. Class H Income Statement

Last quarter (Q3 2024), Pharmaron Beijing Co., Ltd. Class H's total revenue was ¥3.21B, an increase of 10.02% from the same quarter last year. In Q3, Pharmaron Beijing Co., Ltd. Class H's net income was ¥308.40M. See Pharmaron Beijing Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 11.54B¥ 10.27B¥ 7.44B¥ 5.13B¥ 3.76B
Gross Profit
¥ 4.12B¥ 3.77B¥ 2.68B¥ 1.92B¥ 1.33B
Operating Expenses
¥ 2.28B¥ 2.02B¥ 1.15B¥ 838.94M¥ 630.23M
Depreciation and Amortization
¥ 927.17M¥ 696.18M¥ 497.92M¥ 375.16M¥ 317.67M
EBITDA
¥ 2.95B¥ 2.53B¥ 2.49B¥ 1.72B¥ 1.03B
Operating Income
¥ 1.85B¥ 1.69B¥ 1.91B¥ 1.32B¥ 631.49M
Other Income/Expenses
¥ -10.01M¥ -23.50M¥ -3.34M¥ -4.47M¥ 1.06M
Pretax Income
¥ 1.84B¥ 1.67B¥ 1.91B¥ 1.32B¥ 632.55M
Net Income
¥ 1.60B¥ 1.37B¥ 1.66B¥ 1.17B¥ 547.19M
Per Share Metrics
Basic EPS
¥ 0.90¥ 1.16¥ 1.40¥ 0.99¥ 0.55
Diluted EPS
¥ 0.90¥ 1.16¥ 1.37¥ 0.99¥ 0.55
Weighted Average Shares Outstanding
1.77B 1.18B 1.21B 1.19B 991.05M
Weighted Average Shares Outstanding (Diluted)
1.78B 1.18B 1.21B 1.19B 991.05M
Currency in CNY

Pharmaron Beijing Co., Ltd. Class H Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis